{"favorite_id": 10066, "calc_type": "", "dosing": false, "full_title_en": "DIPSS (Dynamic International Prognostic Scoring System) for Myelofibrosis", "short_title_en": "DIPSS", "medium_description_en": "Estimates survival in patients with primary myelofibrosis.", "short_description_en": "Primary myelofibrosis survival.", "before_use": "", "instructions_en": "", "purpose_en": ["Prognosis"], "disease_en": ["Autoimmune Disorders", "Cancer", "Chronic Pain"], "specialty_en": ["Hematology and Oncology"], "chief_complaint_en": [], "system_en": ["Endocrine and Metabolic", "Hematologic", "Immunologic", "Oncologic"], "search_abbreviation_en": ["PMF", "DIPSS score", " DIPSS", "myleofibrosis"], "slug": "dipss-dynamic-international-prognostic-scoring-system-myelofibrosis", "seo": {"meta_description_en": "The DIPSS in myelofibrosis estimates survival for patients with primary myelofibrosis. ", "keywords_en": "DIPSS, Myelofibrosis, PMF, MPN"}, "content": {"how_to_use": {"use_case_en": "<p>Do you use the DIPSS in Myelofibrosis and want to contribute your expertise? <a href=\"https://www.mdcalc.com/join-us\" target=\"_blank\">Join</a> our contributor team!</p>", "pearls_pitfalls_en": "", "why_use_en": ""}, "next_steps": {"advice_en": "<p>Do you use the DIPSS in Myelofibrosis and want to contribute your expertise?&nbsp;<a href=\"https://www.mdcalc.com/join-us\" target=\"_blank\">Join</a>&nbsp;our contributor team!</p>", "management_en": "", "critical_actions_en": ""}, "about": {"formula_en": "<p dir=\"ltr\">Addition of the selected points:</p>\n<p><span id=\"docs-internal-guid-2bb86560-cd99-d4df-2e1a-a8b5076c66f4\"></span></p>\n<div dir=\"ltr\">\n<table><colgroup><col width=\"*\" /><col width=\"*\" /><col width=\"*\" /><col width=\"*\" /></colgroup>\n<tbody>\n<tr>\n<td>\n<p dir=\"ltr\"><strong>Variable </strong></p>\n</td>\n<td>\n<p dir=\"ltr\"><strong>0 points</strong></p>\n</td>\n<td>\n<p dir=\"ltr\"><strong>1 point</strong></p>\n</td>\n<td>\n<p dir=\"ltr\"><strong>2 points</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Age, years</p>\n</td>\n<td>\n<p dir=\"ltr\">&le;65</p>\n</td>\n<td>\n<p dir=\"ltr\">&gt;65</p>\n</td>\n<td>\n<p dir=\"ltr\">--</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">White blood cell count, x10<sup>9</sup>/dL</p>\n</td>\n<td>\n<p dir=\"ltr\">&le;25</p>\n</td>\n<td>\n<p dir=\"ltr\">&gt;25</p>\n</td>\n<td>\n<p dir=\"ltr\">--</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Hemoglobin, g/dL</p>\n</td>\n<td>\n<p dir=\"ltr\">&ge;10</p>\n</td>\n<td>\n<p dir=\"ltr\">--</p>\n</td>\n<td>\n<p dir=\"ltr\">&lt;10</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Peripheral blood blasts</p>\n</td>\n<td>\n<p dir=\"ltr\">&lt;1%</p>\n</td>\n<td>\n<p dir=\"ltr\">&ge;1%</p>\n</td>\n<td>\n<p dir=\"ltr\">--</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Constitutional symptoms</p>\n</td>\n<td>\n<p dir=\"ltr\">No</p>\n</td>\n<td>\n<p dir=\"ltr\">Yes</p>\n</td>\n<td>\n<p dir=\"ltr\">--</p>\n</td>\n</tr>\n</tbody>\n</table>\n</div>", "more_info_en": "<p dir=\"ltr\">Interpretation:</p>\n<p><span id=\"docs-internal-guid-7f973dc9-7fff-f2b7-2da1-eae55a7560a6\"></span></p>\n<div dir=\"ltr\">\n<table><colgroup><col width=\"106\" /><col width=\"114\" /><col width=\"114\" /></colgroup>\n<tbody>\n<tr>\n<td>\n<p dir=\"ltr\"><strong>DIPSS Score</strong></p>\n</td>\n<td>\n<p dir=\"ltr\"><strong>Risk category </strong></p>\n</td>\n<td>\n<p dir=\"ltr\"><strong>Median&nbsp;survival</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">0</p>\n</td>\n<td>\n<p dir=\"ltr\">Low</p>\n</td>\n<td>\n<p dir=\"ltr\">Not reached</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">1&ndash;2</p>\n</td>\n<td>\n<p dir=\"ltr\">Intermediate-1</p>\n</td>\n<td>\n<p dir=\"ltr\">14.2 years</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">3&ndash;4</p>\n</td>\n<td>\n<p dir=\"ltr\">Intermediate-2</p>\n</td>\n<td>\n<p dir=\"ltr\">4 years</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">5&ndash;6</p>\n</td>\n<td>\n<p dir=\"ltr\">High</p>\n</td>\n<td>\n<p dir=\"ltr\">1.5 years</p>\n</td>\n</tr>\n</tbody>\n</table>\n</div>", "evidence_based_medicine_en": "", "references_list": {"Original/Primary Reference": [{"href": "http://www.bloodjournal.org/content/115/9/1703.long?sso-checked=true", "text": "Passamonti F, Cervantes F, Vannucchi AM, et al. A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment). Blood. 2010;115(9):1703-8."}], "Other References": [{"href": "", "text": ""}], "Validation": [{"href": "https://www.ncbi.nlm.nih.gov/pubmed/21149668 ", "text": "Gangat N, Caramazza D, Vaidya R, et al. DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status. J Clin Oncol. 2011;29(4):392-7."}, {"href": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5335805/ ", "text": "Rumi E, Cazzola M. Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms. Blood. 2017;129(6):680-692."}], "Clinical Practice Guidelines": [{"href": "", "text": ""}], "Manufacturer Website": [{"href": "", "text": ""}], "Outcomes": [{"href": "", "text": ""}]}}, "contributor": {"expert_name": []}, "creator": [{"name": "Dr. Francesco Passamonti", "creator_info": {"about_en": "<p>Francesco Passamonti, MD, is the head of the hematology department at the Circolo Hospital and Macchi Foundation, in Varese, Italy. Previously, he was an assistant professor of hematology at the University of Pavia in Pavia, Italy. Dr. Passamonti\u2019s research focuses primarily on Philadelphia-negative myeloproliferative neoplasms (MPN), polycythemia vera, essential thrombocythemia, and myelofibrosis.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-francesco-passamonti.jpg", "pubmedLink": "https://www.ncbi.nlm.nih.gov/pubmed/?term=Passamonti+F%5BAuthor%5D"}}], "related_resources": {"mdcalc_rating": {"evidence": "", "clinical": "", "popularity": ""}, "guidelines": [], "teaching": [], "videos": [], "interests": [], "partner_contact": [], "sdm_tool": []}}, "input_schema": [{"type": "radio", "label_en": "Age, years", "name": "age", "options": [{"label": "\u226465", "value": 0}, {"label": ">65", "value": 1}], "conditionality": "", "show_points": true, "default": 0, "optional": false}, {"type": "radio", "label_en": "White blood cell count, x10\u2079/dL", "name": "wbc", "options": [{"label": "\u226425", "value": 0}, {"label": ">25", "value": 1}], "conditionality": "", "show_points": true, "default": 0, "optional": false}, {"type": "radio", "label_en": "Hemoglobin, g/dL", "name": "hb", "options": [{"label": "\u226510", "value": 0}, {"label": "<10", "value": 2}], "conditionality": "", "show_points": true, "default": 0, "optional": false}, {"type": "radio", "label_en": "Peripheral blood blasts", "name": "blood", "options": [{"label": "<1%", "value": 0}, {"label": "\u22651%", "value": 1}], "conditionality": "", "show_points": true, "default": 0, "optional": false}, {"type": "radio", "label_en": "Constitutional symptoms ", "name": "symptoms", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "conditionality": "", "show_points": true, "default": 0, "optional": false}], "md5": "5f14fbc62fd55ad3f6693f20e487604d", "related_calcs": [{"calcId": 10040, "short_title_en": "Duval/CIBMTR Score", "slug": "duval-cibmtr-score-acute-myelogenous-leukemia-aml-survival"}, {"calcId": 10085, "short_title_en": "SLICS", "slug": "subaxial-injury-classification-severity-scale-slics"}, {"calcId": 10071, "short_title_en": "REVEAL Score for PAH", "slug": "reveal-registry-risk-score-pulmonary-arterial-hypertension-pah"}]}